本文へ移動
cccskills
無料GitHub で公開

es-cushing-patient-family-education

This skill provides structured education to patients and families about Cushing's syndrome pathophysiology, treatment options, and post-remission expectations. It is triggered when a clinician encounters a new Cushing's syndrome patient or family needing disease information, such as at initial diagnosis or before treatment initiation.

インストール方法を見る

含まれるファイル(1)

  • SKILL.md2.5 KB

SKILL.md(原文)

インストールする前に、エージェントに与えられる指示の中身を確認できます。

Patient and Family Education About Cushing's Syndrome

STEP 1 — Gather Information

Confirm biochemical diagnosis of Cushing's syndrome (UFC, late-night salivary cortisol, dexamethasone suppression), determine etiology (pituitary MRI, petrosal sinus sampling, adrenal CT), note planned treatment modality, list comorbidities (diabetes, hypertension, psychiatric disorders, osteoporosis), assess baseline knowledge, concerns, and health literacy of patient and family.

STEP 2 — Rule In / Rule Out

Decide whether the patient/family requires initial education about Cushing's syndrome (new diagnosis, upcoming treatment, or post-remission) versus needing only reinforcement or no education; if education is needed, proceed to stratification, otherwise consider brief updates or skip.

STEP 3 — Classify or Stratify

Stratify by treatment phase: pre-treatment (awaiting surgery/medical/radiation), post-treatment (immediate postoperative), or long-term remission (post-recovery); tailor education depth and focus to the phase.

STEP 4 — Decide

Deliver education covering disease basics, specific treatment plan, expected benefits and risks, postoperative care, glucocorticoid withdrawal symptoms, recurrence monitoring, lifestyle modifications, and available support resources.

Clinical Guardrails / Mimics / Pitfalls

Do not delay definitive treatment for extensive education; avoid unrealistic cure expectations; never omit discussion of lifelong monitoring and comorbidity management; refrain from giving specific medication dosing advice; ensure materials are culturally appropriate and health‑literacy sensitive.

Concrete Clinical Example

A 42‑year‑old man with newly diagnosed ectopic ACTH syndrome from a bronchial carcinoid tumor is scheduled for preoperative ketoconazole; after confirming diagnosis and noting diabetes and hypertension, the clinician educates him and his wife about ectopic CS, ketoconazole side effects, glucose monitoring, and signs of adrenal insufficiency.

Source: Treatment of Cushing’s Syndrome: An Endocrine Society Clinical Practice Guideline, Nieman et al., 2015, DOI:10.1210/jc.2015-1818

レビュー

まだレビューはありません。使ってみた感想をお寄せください。

同じリポジトリのスキル

概要と使いどころ

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

dromlakhani のスキルをすべて見る

このスキルの問題を報告する